CircRNA PIP5K1A Promotes the Progression of Glioma Through Upregulation of the TCF12/PI3K/AKT Pathway by Sponging MiR-515-5p
Overview
Affiliations
Background: Increasing studies have revealed that circular RNAs (CircRNAs) make great contributions to regulating tumor progression. Therefore, we intended to explore the expression characteristics, function, and related mechanisms of a novel type of circRNA, PIP5K1A, in glioma.
Methods: Firstly, reverse transcription-polymerase chain reaction (RT-PCR) was carried out to examine CircPIP5K1A expression in glioma tissues and adjacent normal tissues, and the correlation between CircPIP5K1A level and the clinical-pathological indicators of glioma was analyzed. Then, the CircPIP5K1A expression in various glioma cell lines was detected, and CircPIP5K1A overexpression and knockdown cell models were constructed. Subsequently, cell proliferation and viability were detected by the CCK8 method and BrdU staining. Cell apoptosis was detected by flow cytometry, and cell invasion was examined by Transwell assay. The expression of TCF12, PI3K/AKT pathway apoptotic related proteins (Caspase3, Bax, and Bcl2) and epithelial-mesenchymal transition (EMT) markers (E-cadherin, Vimentin, and N-cadherin) was determined by western blot or RT-PCR.
Results: The results manifested that CircPIP5K1A was upregulated in glioma tissues (compared with that in normal adjacent tissues), and overexpressed CircPIP5K1A was related to glioma volume and histopathological grade. Functionally, overexpressing CircPIP5K1A notably elevated glioma cell proliferation, invasion, and EMT and inhibited apoptosis both in vivo and in vitro. Besides, CircPIP5K1A upregulated TCF12 and PI3K/AKT activation. Bioinformatics analysis testified that miR-515-5p was a common target of CircPIP5K1A and TCF12, while the dual-luciferase reporter assay and RNA immunoprecipitation (RIP) experiment further confirmed that CircPIP5K1A targeted miR-515-5p, which bound the 3'-untranslated region (UTR) of TCF12.
Conclusions: Overall, the study illustrated that CircPIP5K1A is a potential prognostic marker in glioma and regulates glioma evolvement by modulating the miR-515-5p-mediated TCF12/PI3K/AKT axis.
Mendez-Garcia A, Bravo-Vazquez L, Sahare P, Paul S Genes (Basel). 2025; 16(2).
PMID: 40004477 PMC: 11855573. DOI: 10.3390/genes16020148.
Regulation of autophagy by non-coding RNAs in human glioblastoma.
Molavand M, Ebrahimnezhade N, Kiani A, Yousefi B, Nazari A, Majidinia M Med Oncol. 2024; 41(11):260.
PMID: 39375229 DOI: 10.1007/s12032-024-02513-3.
Emerging roles of CircRNA-miRNA networks in cancer development and therapeutic response.
Hashemi M, Khosroshahi E, Daneii P, Hassanpoor A, Eslami M, Koohpar Z Noncoding RNA Res. 2024; 10:98-115.
PMID: 39351450 PMC: 11440256. DOI: 10.1016/j.ncrna.2024.09.006.
The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways.
Mafi A, Hedayati N, Kahkesh S, Khoshayand S, Alimohammadi M, Farahani N Noncoding RNA Res. 2024; 9(4):1178-1189.
PMID: 39022676 PMC: 11250881. DOI: 10.1016/j.ncrna.2024.05.010.
Osteosarcoma in a ceRNET perspective.
Mosca N, Alessio N, Di Paola A, Marrapodi M, Galderisi U, Russo A J Biomed Sci. 2024; 31(1):59.
PMID: 38835012 PMC: 11151680. DOI: 10.1186/s12929-024-01049-y.